Cargando…
346 Clinical Effects of Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, on Patients with Autoimmune and Allergic Diseases
BACKGROUND: A humanized anti-interleukin-6 receptor, tocilizumab, has been approved as a biological drug for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis and Castleman's disease. Since dysregulation of IL-6 production also plays a pathologic role in other variou...
Autores principales: | Tanaka, Toshio, Morishima, Atsuyoshi, Hishitani, Yoshihiro, Yoshida, Yuji, Nakabayashi, Akihiko, Ogawa, Masako, Kawai, Mari, Hirano, Toru, Hagihara, Keisuke, Shima, Yoshihito, Narazaki, Masashi, Ogata, Atsushi, Kishimoto, Tadamitsu, Kumanogoh, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513059/ http://dx.doi.org/10.1097/01.WOX.0000412109.80532.b7 |
Ejemplares similares
-
572 Effect of Enzymatically Modified Isoquercitrin, a Flavonoid, on Symptoms of Japanese Cedar Pollinosis
por: Tanaka, Toshio, et al.
Publicado: (2012) -
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
por: Shima, Yoshihito, et al.
Publicado: (2010) -
Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012) -
494 Skin Sensitization to Carmine Before Onset of Systemic Allergy to Ingested Carmine
por: Katada, Yoshinori, et al.
Publicado: (2012) -
177 Effect of EPA-DHA Supplementation on Forced Expiratory Volume in One Second (FEV1) and Triglycerides in Obese Adolescents With Hypertriglyceridemia
por: Berreondo, Nancy Mendez
Publicado: (2012)